scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0165-0270(97)00097-6 |
P698 | PubMed publication ID | 9350970 |
P2093 | author name string | Yaksh TL | |
Ozaki GT | |||
Dirig DM | |||
Salami A | |||
Rathbun ML | |||
P2860 | cites work | A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 |
Response latencies in the tail-flick test depend on tail skin temperature | Q34176936 | ||
The tail-flick and formalin tests in rodents: changes in skin temperature as a confounding factor | Q40834630 | ||
Role of thermoreceptive afferents in behavioral reaction times to warming temperature shifts applied to the monkey's face | Q41347337 | ||
Inhibition of spinal neuronal responses to noxious skin heating by stimulation of mesencephalic periaqueductal gray in the cat | Q41454452 | ||
Rat tail flick reflex: magnitude measurement of stimulus-response function, suppression by morphine and habituation | Q46063352 | ||
A system to measure thermal nociception | Q46114069 | ||
Effect of interstimulus interval on perceived sensation and intradental nerve activity during thermal tooth stimulation in man. | Q48188323 | ||
Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
Release of cold-induced burning pain by block of cold-specific afferent input | Q48920711 | ||
Response properties of high-threshold cutaneous cold receptors in the primate | Q48920757 | ||
Central suppression of cold-induced C fibre pain by myelinated fibre input. | Q51749038 | ||
Single C nociceptor responses and psychophysical parameters of evoked pain: effect of rate of rise of heat stimuli in humans | Q67580579 | ||
A model of peripheral mononeuropathy in the rat | Q68487260 | ||
A quantitative study on the tail flick test in the rat | Q69002311 | ||
Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processing | Q71940261 | ||
The thermal grill illusion: unmasking the burn of cold pain | Q72041232 | ||
Characterization of the foot withdrawal response to noxious radiant heat in the rat | Q72542502 | ||
P433 | issue | 2 | |
P304 | page(s) | 183-191 | |
P577 | publication date | 1997-10-01 | |
P1433 | published in | Journal of Neuroscience Methods | Q15764020 |
P1476 | title | Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. | |
P478 | volume | 76 |
Q39908449 | A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia |
Q44483117 | A double-lumen intrathecal catheter for studies of modulation of spinal opiate tolerance |
Q37138251 | A modified Hargreaves' method for assessing threshold temperatures for heat nociception |
Q45943942 | A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat. |
Q89156175 | ATF2, but not ATF3, participates in the maintenance of nerve injury-induced tactile allodynia and thermal hyperalgesia |
Q92227580 | Ablation of spinal cord estrogen receptor α-expressing interneurons reduces chemically induced modalities of pain and itch |
Q41780863 | Acetaminophen prevents hyperalgesia in central pain cascade |
Q34515061 | Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. |
Q36678449 | Activated polymorphonuclear cells promote injury and excitability of dorsal root ganglia neurons |
Q30674933 | Acute pain measurement in animals. Part 1 |
Q47581635 | Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. |
Q34785603 | Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models. |
Q43906364 | Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents |
Q39838413 | Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism |
Q46190650 | Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase |
Q38365855 | Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior |
Q40639418 | Bromoenol Lactone, an Inhibitor of Calcium-Independent Phospholipase A2, Suppresses Carrageenan-Induced Prostaglandin Production and Hyperalgesia in Rat Hind Paw. |
Q35400818 | Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat. |
Q44590507 | Can Determining the Minimum Alveolar Anesthetic Concentration of Volatile Anesthetic Be Used as an Objective Tool to Assess Antinociception in Animals? |
Q39906178 | Chapter 9 The dorsal horn and hyperalgesia |
Q34203748 | Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis |
Q37009495 | Commonly used preclinical models of pain |
Q44804055 | Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. |
Q43551134 | Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury. |
Q36493860 | Development of a canine nociceptive thermal escape model |
Q45169817 | Diabetes-induced expression of activating transcription factor 3 in mouse primary sensory neurons |
Q42516806 | Differential contributions of A- and C-nociceptors to primary and secondary inflammatory hypersensitivity in the rat. |
Q97594875 | Disrupted function of lactate transporter MCT1, but not MCT4, in Schwann cells affects the maintenance of motor end-plate innervation |
Q37428056 | Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. |
Q37252030 | Effects of intrathecal SNC80, a delta receptor ligand, on nociceptive threshold and dorsal horn substance p release |
Q33997791 | Effects of intrathecal ketamine in the neonatal rat: evaluation of apoptosis and long-term functional outcome |
Q36085652 | Electroacupuncture inhibition of hyperalgesia in an inflammatory pain rat model: involvement of distinct spinal serotonin and norepinephrine receptor subtypes |
Q79847983 | Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury |
Q44489315 | Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation |
Q35684017 | Hedgehog signaling regulates nociceptive sensitization. |
Q37876887 | Hyperthermic effects on behavior |
Q51092892 | Identification and quantification of neuropeptides in naïve mouse spinal cord using mass spectrometry reveals [des-Ser1]-cerebellin as a novel modulator of nociception. |
Q42099980 | Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia |
Q34189539 | In vivo gene knockdown in rat dorsal root ganglia mediated by self-complementary adeno-associated virus serotype 5 following intrathecal delivery |
Q41486452 | Increased miR-132-3p expression is associated with chronic neuropathic pain. |
Q36162021 | Increasing Pain Sensation Eliminates the Inhibitory Effect of Depression on Evoked Pain in Rats |
Q38835644 | Inflammation-induced GluA1 trafficking and membrane insertion of Ca2+ permeable AMPA receptors in dorsal horn neurons is dependent on spinal tumor necrosis factor, PI3 kinase and protein kinase A. |
Q44348612 | Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. |
Q37093006 | Inhibition of spinal cytosolic phospholipase A(2) expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia. |
Q46973494 | Inhibition of spinal protein kinase C blocks substance P-mediated hyperalgesia |
Q44068212 | Inhibition of spinal protein kinase Calpha expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance |
Q33390819 | Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor |
Q43992305 | Intralesion transplantation of serotonergic precursors enhances locomotor recovery but has no effect on development of chronic central pain following hemisection injury in rats |
Q35684345 | Intrathecal clonidine in the neonatal rat: dose-dependent analgesia and evaluation of spinal apoptosis and toxicity. |
Q39485738 | Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats |
Q42285448 | Intrathecal neurosteroids and a neurosteroid antagonist: effects on inflammation-evoked thermal hyperalgesia and tactile allodynia |
Q42276145 | K/BxN serum transfer arthritis as a model of inflammatory joint pain |
Q35597965 | Kv7.2 regulates the function of peripheral sensory neurons |
Q33573018 | MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice |
Q39616660 | Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain. |
Q48072091 | Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis. |
Q48184426 | Modification of local anesthetic-induced antinociception by fentanyl in rats |
Q28240813 | Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21 |
Q64111658 | Music-Enhanced Analgesia and Antiseizure Activities in Animal Models of Pain and Epilepsy: Toward Preclinical Studies Supporting Development of Digital Therapeutics and Their Combinations With Pharmaceutical Drugs |
Q51945491 | Neuropathic pain memory is maintained by Rac1-regulated dendritic spine remodeling after spinal cord injury. |
Q80889544 | Neurotrophin-3 reverses chronic mechanical hyperalgesia induced by intramuscular acid injection |
Q39590831 | Opioid-induced Loss of Local Anesthetic Potency in the Rat Sciatic Nerve |
Q37406653 | Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat |
Q35230707 | Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current |
Q38943677 | Peripheral Neuropathy in Mouse Models of Diabetes |
Q43188585 | Peripheral delta opioid receptors require priming for functional competence in vivo |
Q42428424 | Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etaner |
Q34546785 | Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit. |
Q30431142 | Potential risk of mitomycin C at high concentrations on peripheral nerve structure |
Q52099813 | Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2. |
Q35589944 | Predictive validity of behavioural animal models for chronic pain |
Q28576196 | Pro-nociceptive effects of neuromedin U in rat |
Q48867969 | Pyruvate dehydrogenase kinase 2 and 4 gene deficiency attenuates nociceptive behaviors in a mouse model of acute inflammatory pain |
Q90084353 | Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model |
Q51100991 | Relationship between blood levels and the anti-hyperalgesic effect of ketoprofen in the rat. |
Q35805234 | Role of anoctamin-1 and bestrophin-1 in spinal nerve ligation-induced neuropathic pain in rats. |
Q40771606 | Role of spinal p38alpha and beta MAPK in inflammatory hyperalgesia and spinal COX-2 expression |
Q46879850 | Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db/db) mice |
Q51418961 | Sensory thresholds and the antinociceptive effects of GABA receptor agonists in mice lacking the beta3 subunit of the GABA(A) receptor. |
Q44345633 | Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. |
Q44334449 | Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat. |
Q35023056 | Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury |
Q35945721 | Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis |
Q92139762 | Spinal cord motor neuron plasticity accompanies second-degree burn injury and chronic pain |
Q35940473 | Spinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism |
Q74105932 | Spinal mechanisms underlying A-85380-induced effects on acute thermal pain |
Q34989480 | Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia |
Q35048741 | Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2 |
Q41913159 | Spinal release of tumour necrosis factor activates c-Jun N-terminal kinase and mediates inflammation-induced hypersensitivity. |
Q35629362 | Surgical injury in the neonatal rat alters the adult pattern of descending modulation from the rostroventral medulla |
Q43697187 | The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. |
Q44330109 | The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. |
Q87782865 | The effect of acclimatization and ambient temperature on heat withdrawal threshold in rats |
Q24288817 | The search for novel analgesics: targets and mechanisms |
Q33679499 | The spinal biology in humans and animals of pain states generated by persistent small afferent input |
Q89340977 | Therapeutic potential of Pak1 inhibition for pain associated with cutaneous burn injury |
Q43821485 | Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice |
Q45029579 | Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability |
Q28574005 | Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal Hyperexcitability Associated with Central Neuropathic Pain after Spinal Cord Injury |
Q33987944 | Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal rat |
Q35598263 | X-linked spinal muscular atrophy in mice caused by autonomous loss of ATP7A in the motor neuron |
Q43010980 | Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY. |
Q33709635 | miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats |
Q37854049 | α2C-adrenoceptor modulators: a patent review |
Search more.